Gastric cancer currently ranks fourth in cancer-related mortality worldwide. In the western
world, it is most often diagnosed at an advanced stage, after becoming metastatic at distant …

Gastric cancer is responsible for a high burden of disease globally. Although more extensive
use of chemotherapy together with the recent introduction of the two targeted agents …

No standard adjuvant or palliative chemotherapy regimen has been internationally
approved for patients with advanced gastric cancer. Adjuvant chemoradiotherapy is …

Adequately powered, randomized phase III trials are necessary to define the clinical role of
targeted therapies in advanced gastric cancer. Biomarker studies to correlate with treatment …

Opinion statement Despite a decreasing incidence in the USA, gastric cancer is highly
prevalent worldwide. Furthermore, gastric cancer remains highly lethal with median survival …

Despite advances in the treatment of gastric cancer, it remains the world's second highest
cause of cancer death. As gastric cancer is often diagnosed at an advanced stage, systemic …

The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in
recent years. We have reviewed the recent data of clinical trial incorporating targeted …

The optimal medical treatment for advanced gastric cancer is currently the source of debate.
Cytotoxic treatment has been shown to prolong survival and provide improved symptom …

Gastric cancer is the third leading cause of cancer mortality worldwide. As surgery is the only
curative treatment strategy and conventional chemotherapy has shown limited efficacy-with …

In the setting of metastatic or inoperable gastric cancer, the current evidence shows that
chemotherapy improves survival in comparison to best supportive care and that combination …